|
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 96.75% | Shs Outstand | 23.83M | Perf Week | -9.42% |
| Market Cap | 453.45M | Forward P/E | - | EPS next Y | - | Insider Trans | 3.95% | Shs Float | 0.31M | Perf Month | - |
| Income | - | PEG | - | EPS next Q | - | Inst Own | 17.34% | Short Float | - | Perf Quarter | - |
| Sales | 41.14M | P/S | 11.02 | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Book/sh | - | P/B | - | EPS next Y | - | ROA | - | Target Price | - | Perf Year | - |
| Cash/sh | - | P/C | - | EPS next 5Y | - | ROE | - | 52W Range | 18.52 - 27.38 | Perf YTD | -23.76% |
| Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | - | 52W High | -30.50% | Beta | - |
| Dividend % | - | Quick Ratio | - | Sales past 5Y | - | Gross Margin | - | 52W Low | 2.77% | ATR | 2.23 |
| Employees | - | Current Ratio | - | Sales Q/Q | - | Oper. Margin | - | RSI (14) | - | Volatility | 11.69% - |
| Optionable | No | Debt/Eq | - | EPS Q/Q | - | Profit Margin | - | Rel Volume | 0.66 | Prev Close | 20.12 |
| Shortable | Yes | LT Debt/Eq | - | Earnings | - | Payout | - | Avg Volume | 485.06K | Price | 19.03 |
| Recom | - | SMA20 | -17.99% | SMA50 | -17.99% | SMA200 | -17.99% | Volume | 320,128 | Change | -5.42% |
 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
| NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
|
| open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite